| Maloneys Custom Ocular Prosthetics | |
| 4500 Kruseway, Plaza 1, Suite 300, Lake Oswego, Oregon 97035 | |
| (503) 675-1320 |
| Name | Maloneys Custom Ocular Prosthetics |
|---|---|
| Organization Name | Maloney's Custom Ocular Prosthetics, Inc. |
| Location | 4500 Kruseway, Plaza 1, Suite 300, Lake Oswego, Oregon 97035 |
| Type | Supplier |
| Phone | (503) 675-1320 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Compugen Ltd. (NASDAQ: CGEN) announced today the development of "NexGen," a new platform designed to significantly enhance Compugen's overall infrastructure for predictive drug and drug target discovery. NexGen is designed to analyze Next Generation Sequencing data which is now beginning to be generated worldwide through RNA-Seq methodology.
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
When "T" started kindergarten, she was an independent, confident child who was fully able to move about in her new environment—even though she was the only visually impaired child in her school and used a long cane. T was born in 2003 with Leber's congenital amaurosis, a rare inherited eye disease, and has no light perception. She was introduced to the long cane at the early age of 14 months to foster her independence of mobility and functioning.
CSafe Global, the world's largest producer of actively controlled mobile refrigeration units for biopharmaceutical and healthcare applications, has released a white paper highlighting the problems and risk associated with using poorly maintained container stock.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 8 days ago
News Archive
Compugen Ltd. (NASDAQ: CGEN) announced today the development of "NexGen," a new platform designed to significantly enhance Compugen's overall infrastructure for predictive drug and drug target discovery. NexGen is designed to analyze Next Generation Sequencing data which is now beginning to be generated worldwide through RNA-Seq methodology.
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
When "T" started kindergarten, she was an independent, confident child who was fully able to move about in her new environment—even though she was the only visually impaired child in her school and used a long cane. T was born in 2003 with Leber's congenital amaurosis, a rare inherited eye disease, and has no light perception. She was introduced to the long cane at the early age of 14 months to foster her independence of mobility and functioning.
CSafe Global, the world's largest producer of actively controlled mobile refrigeration units for biopharmaceutical and healthcare applications, has released a white paper highlighting the problems and risk associated with using poorly maintained container stock.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.
› Verified 8 days ago
Sav-on Pharmacy #3531 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 16199 Boones Ferry Rd, Lake Oswego, Oregon 97035 Phone: (503) 635-0914 | |
Lake Oswego Foot Clinic Type: Medicare Supplier Location: 15573 Bangy Rd, Lake Oswego, Oregon 97035 Phone: (503) 636-9656 | |
Maloneys Custom Ocular Prosthetics Type: Medicare Supplier Location: 4500 Kruseway, Plaza 1, Lake Oswego, Oregon 97035 Phone: (503) 675-1320 | |
National Seating & Mobility Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5820 Jean Rd, Lake Oswego, Oregon 97035 Phone: (423) 756-2268 | |
Sight Shop Type: Eyewear Supplier (Equipment, not the service) Location: 9 Monroe Pkwy, Lake Oswego, Oregon 97035 Phone: (503) 699-7832 |